RxDoctor Payments Data

Marie Ann Korallus, APRN

Family · Countryside, ILNPI 1669927893

Payments from drug & device makers

$625in general payments, 2019–2025

Across 18 payments — averaging $34.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$341
  • AbbVie$115
  • Edwards Lifesciences$27
  • Novo Nordisk$26
  • Mylan Specialty L.p.$24
  • Dexcom, Inc.$23
  • plus $69 from 4 others

What the payments were for

  • Food & beverage$625100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Lilly USA, LLC8$341
AbbVie2$115
Edwards Lifesciences1$27
Novo Nordisk1$26
Mylan Specialty L.p.1$24
Dexcom, Inc.1$23
Metacel Pharmaceuticals LLC1$18
Lexicon Pharmaceuticals, Inc.1$18
Pfizer1$17
Exact Sciences1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$625 in reported general payments places this provider in the 65th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois

Medicare billing

Part B allowed, 2024
$18,236
Medicare patients
69
Services billed
272

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin15$883
FenofibrateFenofibrate Nanocrystallized26$460
Fluticasone Propionate27$405
Levothyroxine Sodium24$403
Pantoprazole Sodium18$381
Atorvastatin Calcium54$355
Albuterol Sulfate HfaAlbuterol Sulfate15$320
Metoprolol Succinate17$309
Metformin Hcl14$275
Simvastatin11$218
Tamsulosin Hcl12$154
Alendronate Sodium15$141
Losartan Potassium11$124
Rosuvastatin Calcium12$115
Omeprazole14$93

Paid to pharmacies, not to this prescriber.

Other family in Countryside

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →